表紙
市場調査レポート

米国における血液銀行市場の展望:成長機会と戦略

US Blood Banking Market 2014: Innovations, Trends and Opportunities for Suppliers

発行 Venture Planning Group 商品コード 237409
出版日 ページ情報 英文
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=101.50円で換算しております。

Local License: 同一事業所内

Back to Top
米国における血液銀行市場の展望:成長機会と戦略 US Blood Banking Market 2014: Innovations, Trends and Opportunities for Suppliers
出版日: ページ情報: 英文
担当者のコメント
このシリーズは、他にも調査対象国がございます。詳細はお問合せください。
概要

当レポートでは、米国における血液銀行(Blood Banking)関連市場の最新動向と 将来展望について分析し、検査技術の研究開発の最新動向、市場の基本構造・動向、 今後の市場動向予測、市場拡大のための戦略と課題、 主要企業プロファイルといった情報を盛り込んで、概略以下の構成でお届けします。

目次

世界の技術と市場概況

A. 主要な血液型検査、分類、および感染症スクリーニング検査

1. 血液型および分類検査

2. 感染症スクリーニング検査

3. 病原体の減少

4. 白血球の減少

B. 装置・機器類概説

  • イントロダクション
  • 1. Abbott Prism
  • 2. Abbott Quantum II
  • 3. Abbott Commander
  • 4. BioMeriuex BacT/Alert
  • 5. Dade Behring Quadriga
  • 6. Dade Behring BEP 2000
  • 7. Grifols Diana
  • 8. Immucor ABS2000
  • 8. Immucor Galile
  • 10. Immucor Rosys Plato
  • 11. Olympus PK7100
  • 12. Olympus PK7200
  • 13. Olympus PK80
  • 14. Olympus BloodTrack Courier
  • 15. Ortho AutoVue/ProVue
  • 16. Ortho Summit Processor
  • 17. Tecan ELPHAtyper
  • 18. Tecan Hemotyper
  • 19. Tecan MegaFlex
  • 20. Tecan MiniSwift

C. 主要な体外診断技術およびその潜在用途

  • 1. 分子診断法
  • 2. モノクローナル/ポリクローナル抗体
  • 3. 免疫測定法
  • 4. マイクロタイタープレート
  • 5. マイクロコンピュータ
  • 6. オートメーション
  • 7. レーザー
  • 8. ロボティックス
  • 9. 人工知能
  • 10. 合成赤血球代替物
  • 11. 遺伝子組み換え血液成分
  • 12. 血液保存
  • 13. 自己血輸血/冷凍

D. 世界市場概況

  • 1. 事業環境
  • 2. 市場構造
  • 3. 市場規模と成長

米国市場

  • A. エグゼクティブ・サマリー
  • B. 事業環境
    • 1. 概要
    • 2. 医療費
    • 3. コスト意識
    • 4. 償還
    • 5. 業界再編
    • 6. マネージド・ケア
    • 7. 病院
    • 8. 入院
    • 9. 入院期間
    • 10. 産業多角化
    • 11. 医師の人口統計
    • 12. 人口の高齢化
    • 13. 研究機関に対する規制
    • 14. FDA の改革
  • C. 市場構造
  • D. 市場規模、成長、主なサプライヤーの消耗品売上、装置・機器の設置、インストールベース、および市場シェア

主要製品の開発機会

  • A. 血液型検査および分類
  • B. 感染症スクリーニング
  • C. 補助装置

代替市場浸透戦略

  • A. 内部開発
  • B. 共同開発契約
  • C. 大学との提携

潜在市場の参入障壁およびリスク

  • A. 市場成熟度
  • B. 費用の抑制
  • C. 競合
  • D. 技術面での優位性と限界
  • E. 特許保護
  • F. 規制による抑制

競合評価

  • Abbott
  • Beckman Coulter
  • Biokit
  • BioMerieux
  • Bio-Rad
  • Bioscot
  • Biotest
  • Chiron
  • Diagast
  • Diamed
  • DiaSorin
  • Fujirebio
  • Gen-Probe
  • Gradipore
  • Grifols
  • ImmucorGamma
  • Innogenetics
  • Orchid Biosciences
  • Ortho-Clinical Diagnostics
  • Proteome Sciences
  • Roche
  • Siemens
  • Tecan

付録: 為替レート予測

表一覧

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: VPBB362-8-2-3

US Blood Banking Market 2014: Innovations, Trends and Opportunities for Supplierst” is a new strategic analysis prepared by Venture Planning Group in order to help current suppliers and potential market entrants identify and evaluate emerging opportunities and assist industry executives in developing effective business, new product development and marketing strategies.

Rationale

During the next five years, the US blood banking market is expected to undergo significant transformation, which will result from the convergence of several trends, including more stringent regulations; advances in diagnostic technologies, IT, system engineering and automation; and intensifying competition.  Some segments will start resembling commodity markets, where product positioning and differentiation are more critical than underlying technology. 

The changes in the marketplace will create exciting opportunities for new instruments and reagent systems, as well as auxiliary products, such as specimen preparation devices, controls, calibrators, and innovative IT applications.

Strategic Recommendations

- New product development opportunities with significant market appeal.- Alternative market penetration strategies.- Potential market entry barriers and risks.

The report explores future marketing and technological trends in the US; provides estimates of the test volume, instrument placements and sales; compares features of major automated and semi-automated analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next ten years.

Blood Typing and Grouping Tests

ABO, Antibody Panels, Antibody Screening/Indirect Antiglobulin, Antigen Typing (C, c, Duffy, E, e, I, i, Kell, Kidd, Le a, b, MN, P, S, s), Antiglobulin (Direct, C3 + IgG, IgG,  C3), Crossmatching (Immediate Spin, Full Crossmatch), Rh (D, Du).

Infectious Disease Screening Tests

AIDS (HIV NAT, HIV-1/2), Cytomegalovirus,Hepatitis (HAV NAT, HBV NAT, HBs Ag,   Anti-HBc, HCV NAT, HCV, ALT/SGPT), HTLV-I/II, Parvovirus B19 NAT, Syphilis, West Nile Virus NAT.

Sales and Market Share Analysis

Sales and market share estimates of leadingsuppliers of blood banking of reagentsand instruments, by individual product.

Competitive Assessments

Strategic assessments of major suppliers and emerging market entrants, including their sales,product portfolios, marketing tactics, and newproducts in R&D.

Market Segmentation Analysis

- Comprehensive market segmentationanalysis, including review of the marketdynamics, trends, structure, size, growth,and key suppliers.

- Test volume and sales forecasts for over 40 blood banking tests, including NAT, by market segment:

- Blood Centers- Plasma Fractionation Facilities- Hospitals- Commercial/Private Laboratories- Military Blood Banks

Current and Emerging Products

- Analysis of current and emerging blood banking tests.

- Review of automated and semi-automatedanalyzers, including their operatingcharacteristics, features, and selling prices.

Technology Review

- Assessment of current and emerging technologies,and their potential applications for the blood banking market.

- Comprehensive lists of companies developingor marketing new technologies and products by test.

Contains: 460 pages and 53 tables.

Table of Contents

Worldwide Technology and Market Overview

  • A. Major Blood Typing, Grouping and Infectious Disease Screening Tests
    • 1. Blood Typing and Grouping Tests
      • a. ABO
      • b. Antibody Panels
      • c. Antibody Screening
      • d. Antigen Typing
      • e. Antiglobulin Test
      • f. Crossmatch
      • g. HLA Typing
      • h. Rh
      • i. Other Blood Groups
    • 2. Infectious Disease Screening Tests
      • a. AIDS
        • Structure and Composition
        • Classification
        • Origin of AIDS
        • Animal Lentivirus Systems
        • Virus Receptors
        • HIV Infections in Humans
          • Pathogenesis & Pathology
          • Overview of Course of HIV Infection
        • CD4T Lymphocytes and Memory Cells
        • Monocytes and Macrophages
        • Lymphoid Organs
        • Neural Cells
        • Viral Coinfections
          • Clinical Findings
        • Plasma Viral Load
        • Pediactric AIDS
          • Neurologic Disease
          • Opportunistic Infections
          • Protozoa
          • Fungi
          • Bacteria
        • Viruses
        • Cancer
        • Immunity
        • Laboratory Diagnosis
          • Virus Isolation
          • Serology
          • Detection of Viral Nucleic Acid or Antigens
        • Epidemiology
          • Worldwide Spread of AIDS
          • United States
          • Routes of Transmission
        • Prevention, Treatment, And Control
          • Antiviral Drugs
          • Vaccines Against HIV
        • Transmission of HIV in Blood Products
        • HIV Transmission in Transplant and Artificial Insemination Recipients
        • Diagnostic Tests
        • Enzyme Immunoassay Interpretation
        • Specificity, Sensitivity, and Predictive Value of Enzyme Immunoassay
        • Competition Assays
        • Western Blot Technique
        • Immuno-Fluorescence Assay (IFA)
        • Radioimmunoprecipitation
        • HIV-1/HIV-2 Combination Testing
        • Methods of HIV-Antigen Detection
        • Antigen Assays and Blood Screening
        • Urine Tests
        • DNA Probes
        • Overview
        • Quantitative Polymerase Chain Reaction
        • In Situ PCR
        • Needed Improvements
        • Viral Load/Drug Resistance Testing
        • Genotype and Phenotype Testing
        • Blood Banking Considerations
      • b. Hepatitis
        • Hepatitis A
        • Hepatitis B
          • Structure and Composition
          • Replication of Hepatitis B Virus
        • Hepatitis C
        • Hepatitis D (Delta Hepatitis)
        • Hepatitis E
        • Hepatitis G
        • Hepatitis Virus Infections In Humans
          • Pathology
        • Clinical Findings
        • Laboratory Features
          • Hepatitis A
          • Hepatitis B
          • Hepatitis C
          • Hepatitis D
          • Hepatitis E
        • Virus-Host Immune Reactions
        • Epidemiology
          • Hepatitis A
          • Hepatitis B
          • Hepatitis C
          • Hepatitis D (Delta Agent)
        • Vaccines and Drugs
      • c. Cytomegalovirus
        • Background
        • Chorioretinitis
        • Gastrointestinal
        • Central Nervous System Disease
        • Diagnostic Tests
        • Vaccines and Drugs
      • d. Syphilis
        • Background
        • Diagnostic Tests
        • Vaccines and Drugs
      • e. West Nile Virus
        • Background
        • Clinical Syndromes
        • Diagnostic Tests
        • Vaccines and Drugs
      • f. Parvovirus B19
        • Microbiology
        • Epidemiology
        • Clinical Syndromes
          • Erythema Infectiosum Slapped (cheek)
          • Adult Polyarthropathy
          • Transient Aplastic Crisis
          • Transient Pancytopenia
          • Red Cell Aplasia in the Immunocompromised
          • Perinatal Infections
        • Diagnosis
        • Treatment
      • g. Creutzfeldt-Jakob's Disease
        • Background
        • Transmission
        • Diagnostic Tests
        • Major Commercial and Academic Players
          • Bayer
          • Disease Sciences/BioTec Global
          • Imperial College School of Medicine
          • Ortho-Clinical Diagnostics
          • Pall
          • ProMetic Life Sciences
          • Proteome Sciencaes/Idexx
          • Q-One Biotech
          • Serono
          • U.S. Agricultural Research Service
        • Drugs
        • Vaccines
      • h. Malaria
      • i. Chagas Disease
      • j. Babesiosis
    • 3. Pathogen Reduction
    • 4. Leukocyte Reduction
      • Background
      • Methods
  • B. Instrumentation Review: Operating Characteristics, Features and Selling Prices of Leading Automated and Semiautomated Analyzers Manufactured by:
    • Abbott
    • Beckman Coulter/Danaher
    • Bio-Rad
    • BioMerieux
    • Gen-Probe
    • Grifols
    • Immucor
    • Nanosphere
    • Ortho-Clinical Diagnostics
    • Roche
    • Sarstedt
    • Siemens
    • Tecan
  • C. Major in Vitro Diagnostic Technologies And Their Potential Applications
    • 1. Molecular Diagnostics
      • a. Overview
      • b. NAT
    • 2. Monoclonal and Polyclonal Antibodies
    • 3. Immunoassays
      • a. Technological Principle
      • b. Chemiluminescence
      • c. Enzyme Immunoassays (EIA)
        • Overview
        • ELISA
        • EMIT
        • Electrochemical
      • d. Radioimmunoassays (RIA)
      • e. Immunoprecipitation
      • f. Affinity Chromatography
    • 4. Microtitration Plates
    • 5. IT and Automation
    • 6. Lasers
    • 7. Robotics
    • 8. Synthetic Red Cell Substitutes
    • 9. Genetically Engineered Blood Components
      • a. Albumin
      • b. Factor VIII
      • c. Alpha-2 Antiplasmin
      • d. Antithrombin III
      • e. Factor IX
      • f. Von Willebrand's Factor
      • g. Fibrinogen
      • h. t-PA
    • 10. Blood Preservation
    • 11. Autologous Blood Transfusion/Freezing

U.S.A.

  • A. Executive Summary
  • B. Business Environment
    • 1. Overview
    • 2. Health Care Expenditures
    • 3 Cost Consciousness
    • 4. Industry Consolidation
    • 5. Managed Care
    • 6. Hospitals
    • 7. Admissions
    • 8. Length of Stay
    • 9. Industry Diversification
    • 10. Physician Demographics
    • 11. Population Aging
      • a. Chronic Illnesses
      • b. Disease Incidence
      • c. Susceptibility to Latrogenesis
      • d. Multiple Illness Cases
    • 12. Laboratory Regulations
  • C. Market Structure
  • D. Market Size, Growth and Major Suppliers' Sales and Market Shares for Blood Typing, Grouping and Infectious Disease Screening Tests

Major Product Development Opportunities

  • A. Blood Typing and Grouping
  • B. Infectious Disease Screening
  • C. Auxiliary

Alternative Market Penetration Strategies

  • A. Internal Development
  • B. Collaborative Arrangements
  • C. University Contracts

Potential Market Entry Barriers and Risks

  • A. Market Maturity
  • B. Cost Containment
  • C. Competition
  • D. Technological Edge and Limitations
  • E. Patent Protection

Competitive Assessments

  • Abbott
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • Biokit
  • BioMerieux
  • Bio-Rad
  • Diagast
  • DiaSorin
  • Fujirebio
  • Gen-Probe
  • Grifols
  • Immucor
  • Innogenetics
  • Ortho-Clinical Diagnostics
  • Orchid CellMark
  • Novartis Diagnostics
  • Proteome Sciences
  • Roche
  • Siemens
  • Tecan

List of Tables

  • Major Companies Developing or Marketing Blood Typing and Grouping Tests
  • Major Companies Developing or Marketing HLA Typing Tests
  • Major Companies Developing or Marketing AIDS Tests
  • Major Companies Developing or Marketing Hepatitis Tests
  • Major Companies Developing or Marketing CMV Tests
  • Major Companies Developing or Marketing Syphilis Tests
  • Major Companies Developing or Marketing Blood Bank Analyzers
  • Executive Summary Table: U.S.A., Total Blood Bank Test Volume and Reagent Sales Forecast by Test Category
  • U.S.A., Estimated Number of Inpatient and Ambulatory Surgeries
  • U.S.A., Facilities Performing Blood Bank Tests by Market Segment
  • U.S.A., Hospital Laboratories Performing Blood Bank Tests by Bed Size
  • U.S.A., Commercial/Private Laboratories Performing Blood Bank Tests by Annual Test Volume Forecast
  • U.S.A., Facilities Collecting Whole Blood And Plasma by Market Forecast Segment
  • U.S.A., Whole Blood and Plasma Collections By Market Forecast Segment
  • U.S.A., All Market Segments Blood Typing and Grouping Test Volume by Market Forecast Segment
  • U.S.A., All Market Segments Blood Typing And Grouping Test Volume Forecast
  • U.S.A., Hospital Laboratories Blood Typing and Grouping Test Volume Forecast
  • U.S.A., Community and Regional Blood Centers Blood Typing and Grouping Test Volume Forecast
  • U.S.A., Commercial/Private Laboratories Blood Typing and Grouping Test Volume Forecast
  • U.S.A., Plasma Fractionation Centers Blood Typing and Grouping Test Volume Forecast
  • U.S.A., Military Blood Banks Blood Typing and Grouping Test Volume Forecast
  • U.S.A., All Market Segments Infectious Disease Screening Test Volume Forecast By Market Segment
  • U.S.A., All Market Segments Infectious Disease Screening Test Volume Forecast
  • U.S.A., Community and Regional Centers Infectious Disease Screening Test Volume Forecast
  • U.S.A., Plasma Fractionation Centers Infectious Disease Screening Test Volume Forecast
  • U.S.A., Hospital Blood Banks Infectious Disease Screening Test Volume Forecast
  • U.S.A., Military Blood Banks Infectious Disease Screening Test Volume Forecast
  • U.S.A., All Market Segments Blood Typing And Grouping Reagent Market Forecast by Market Segment
  • U.S.A., All Market Segments Blood Typing And Grouping Reagent Market Forecast by Market Segment
  • U.S.A., Hospital Blood Banks Blood Typing And Grouping Reagent Market Forecast by Major Test
  • U.S.A., Community and Regional Blood Centers Blood Typing and Grouping Reagent Market Forecast By Major Test
  • U.S.A., Commercial/Private Laboratories Blood Typing and Grouping Reagent Market Forecast By Major Test
  • U.S.A., Plasma Fractionation Centers Blood Typing and Grouping Reagent Market Forecast By Major Test
  • U.S.A., Military Blood Banks Blood Typing And Grouping Reagent Market Forecast by Major Test
  • U.S.A., All Market Segments Infectious Disease Screening Reagent Market by Market Forecast Segment
  • U.S.A., All Market Segments Infectious Disease Screening Reagent Market by Market Forecast Segment
  • U.S.A., Community and Regional Centers Infectious Disease Screening Reagent Market Forecast By Test
  • U.S.A., Plasma Fractionation Centers Infectious Disease Screening Reagent Market Forecast By Test
  • U.S.A., Hospital Blood Banks Infectious Disease Screening Reagent Market Forecast By Test
  • U.S.A., Military Blood Banks Infectious Disease Screening Reagent Market Forecast By Test
  • U.S.A., Major Suppliers of Blood Typing And Grouping Reagents Estimated Sales And Market Shares
  • U.S.A., HIV/HTLV Blood Screening Market, Reagent Sales by Major Supplier
  • U.S.A., Hepatitis Blood Screening Market, Reagents Sales by Major Supplier
  • U.S.A., Hepatitis C Blood Screening Market, Reagent Sales By Major Supplier
  • U.S.A., HIV/Hepatitis C NAT Market, Reagent Sales By Major Supplier
  • U.S.A., West Nile Virus NAT Market, Reagent Sales by Major Supplier
  • U.S.A., CMV Blood Screening Market, Reagent Sales by Major Supplier
  • U.S.A., Syphilis Blood Screening Market, Reagent Sales by Major Supplier
Back to Top